Kangji Medical Holdings Limited

9997.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9997.HK stands at 9.1B. In comparison, 1066.HK has a market cap of 27.4B. Regarding current trading prices, 9997.HK is priced at HK$7.73, while 1066.HK trades at HK$6.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9997.HK currently has a P/E ratio of 14.31, whereas 1066.HK's P/E ratio is 12.37. In terms of profitability, 9997.HK's ROE is +0.23%, compared to 1066.HK's ROE of +0.09%. Regarding short-term risk, 9997.HK is more volatile compared to 1066.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9997.HK.

9997.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9997.HK stands at 9.1B. In comparison, 2276.HK has a market cap of 17.5B. Regarding current trading prices, 9997.HK is priced at HK$7.73, while 2276.HK trades at HK$37.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9997.HK currently has a P/E ratio of 14.31, whereas 2276.HK's P/E ratio is 33.23. In terms of profitability, 9997.HK's ROE is +0.23%, compared to 2276.HK's ROE of +0.25%. Regarding short-term risk, 9997.HK is more volatile compared to 2276.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9997.HK.

9997.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9997.HK stands at 9.1B. In comparison, 6699.HK has a market cap of 9.8B. Regarding current trading prices, 9997.HK is priced at HK$7.73, while 6699.HK trades at HK$57.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9997.HK currently has a P/E ratio of 14.31, whereas 6699.HK's P/E ratio is 104.82. In terms of profitability, 9997.HK's ROE is +0.23%, compared to 6699.HK's ROE of +0.03%. Regarding short-term risk, 9997.HK is more volatile compared to 6699.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9997.HK.

9997.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9997.HK stands at 9.1B. In comparison, 1501.HK has a market cap of 4.6B. Regarding current trading prices, 9997.HK is priced at HK$7.73, while 1501.HK trades at HK$25.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9997.HK currently has a P/E ratio of 14.31, whereas 1501.HK's P/E ratio is 21.25. In terms of profitability, 9997.HK's ROE is +0.23%, compared to 1501.HK's ROE of +0.11%. Regarding short-term risk, 9997.HK is more volatile compared to 1501.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9997.HK.

9997.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9997.HK stands at 9.1B. In comparison, 3600.HK has a market cap of 4B. Regarding current trading prices, 9997.HK is priced at HK$7.73, while 3600.HK trades at HK$4.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9997.HK currently has a P/E ratio of 14.31, whereas 3600.HK's P/E ratio is 9.91. In terms of profitability, 9997.HK's ROE is +0.23%, compared to 3600.HK's ROE of +0.15%. Regarding short-term risk, 9997.HK is more volatile compared to 3600.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9997.HK.

9997.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9997.HK stands at 9.1B. In comparison, 6929.HK has a market cap of 2.9B. Regarding current trading prices, 9997.HK is priced at HK$7.73, while 6929.HK trades at HK$3.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9997.HK currently has a P/E ratio of 14.31, whereas 6929.HK's P/E ratio is 9.37. In terms of profitability, 9997.HK's ROE is +0.23%, compared to 6929.HK's ROE of +0.10%. Regarding short-term risk, 9997.HK is more volatile compared to 6929.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9997.HK.

9997.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9997.HK stands at 9.1B. In comparison, 1358.HK has a market cap of 1.7B. Regarding current trading prices, 9997.HK is priced at HK$7.73, while 1358.HK trades at HK$1.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9997.HK currently has a P/E ratio of 14.31, whereas 1358.HK's P/E ratio is 10.27. In terms of profitability, 9997.HK's ROE is +0.23%, compared to 1358.HK's ROE of +0.04%. Regarding short-term risk, 9997.HK is less volatile compared to 1358.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9997.HK.

9997.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9997.HK stands at 9.1B. In comparison, 1942.HK has a market cap of 583.2M. Regarding current trading prices, 9997.HK is priced at HK$7.73, while 1942.HK trades at HK$0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9997.HK currently has a P/E ratio of 14.31, whereas 1942.HK's P/E ratio is -2.55. In terms of profitability, 9997.HK's ROE is +0.23%, compared to 1942.HK's ROE of -0.10%. Regarding short-term risk, 9997.HK is less volatile compared to 1942.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9997.HK.

9997.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9997.HK stands at 9.1B. In comparison, 1120.HK has a market cap of 417.2M. Regarding current trading prices, 9997.HK is priced at HK$7.73, while 1120.HK trades at HK$1.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9997.HK currently has a P/E ratio of 14.31, whereas 1120.HK's P/E ratio is 36.00. In terms of profitability, 9997.HK's ROE is +0.23%, compared to 1120.HK's ROE of +0.02%. Regarding short-term risk, 9997.HK is more volatile compared to 1120.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9997.HK.

9997.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9997.HK stands at 9.1B. In comparison, 0876.HK has a market cap of 95.8M. Regarding current trading prices, 9997.HK is priced at HK$7.73, while 0876.HK trades at HK$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9997.HK currently has a P/E ratio of 14.31, whereas 0876.HK's P/E ratio is -1.90. In terms of profitability, 9997.HK's ROE is +0.23%, compared to 0876.HK's ROE of -0.10%. Regarding short-term risk, 9997.HK is less volatile compared to 0876.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9997.HK.

9997.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9997.HK stands at 9.1B. In comparison, 0907.HK has a market cap of 93.4M. Regarding current trading prices, 9997.HK is priced at HK$7.73, while 0907.HK trades at HK$0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9997.HK currently has a P/E ratio of 14.31, whereas 0907.HK's P/E ratio is -1.53. In terms of profitability, 9997.HK's ROE is +0.23%, compared to 0907.HK's ROE of -5.79%. Regarding short-term risk, 9997.HK is less volatile compared to 0907.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9997.HK.

9997.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9997.HK stands at 9.1B. In comparison, 1134.HK has a market cap of 92M. Regarding current trading prices, 9997.HK is priced at HK$7.73, while 1134.HK trades at HK$0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9997.HK currently has a P/E ratio of 14.31, whereas 1134.HK's P/E ratio is -4.60. In terms of profitability, 9997.HK's ROE is +0.23%, compared to 1134.HK's ROE of -0.13%. Regarding short-term risk, 9997.HK is more volatile compared to 1134.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9997.HK.